The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...
Activation of immune blood biomarkers from interferon gamma pathway distinguished long-term survivors (>=2 years) ...
PulseSight Therapeutics SAS, an ophthalmology clinical stage biotech company developing disruptive vectorized gene therapies with minimally-invasive delivery technology, is pleased to announce the ...
The placebo-controlled, double-blind, randomised Phase I trial involved 100 healthy participants.
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced the results of the global Phase 3 RED-C clinical program evaluating amorphous-rifaximin solid soluble dispersion (SSD) in adults with ...
• In the Phase 1 portion of the CELC-G-201 clinical trial evaluating gedatolisib plusdarolutamide in men with metastatic castration resistant prostate cancer (“mCRPC”),the six-month radiographic ...
Maze Therapeutics, a clinical-stage biopharmaceutical company, announced the dosing of the first patient in its Phase 2 clinical trial, the HORIZON Study, which is investigating MZE829, an oral APOL1 ...
Nummular eczema is a debilitating skin condition that is distinct from atopic dermatitis but involves similar disease mechanisms including IL-13 and therefore makes targeting IL-13 with lebrikizumab a ...
Interim results indicate NS002 demonstrated significantly faster absorption and higher peak epinephrine levels compared to ...
WEP Clinical (WEP), a full-service contract research organization (CRO), announces the acquisition of Siron Clinical (Siron), a Netherlands-based European CRO specializing in flexible, high-quality ...
Many clinical trials include a placebo group—participants who receive an inactive treatment—so researchers can compare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results